MGD019 DART® Protein in Unresectable/Metastatic Cancer

Clinical trial NCT03761017 · COMPLETED

Trial details

NCT number: NCT03761017
Sponsor: MacroGenics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Squamous Cell Non Small Cell Lung Cancer Prostate Cancer Metastatic Cutaneous Melanoma Colorectal Cancer Advanced Cancer Solid Tumor, Adult

Start date: 2018-12-12
Primary completion: 2024-08-29
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.